✦ LIBER ✦

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

✍ Scribed by Oscar Kashala; Roberto Amador; Maria V. Valero; Alberto Moreno; Arnoldo Barbosa; Beatrice Nickel; Claudia A. Daubenberger; Fanny Guzman; Gerd Pluschke; Manuel.E. Patarroyo

Book ID: 117430894
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 206 KB
Volume: 20
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(02)00115-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, immunogenicity and protective ef

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

✍ Fernando Sempértegui; Bertha Estrella; Juan Moscoso; C. Luis Piedrahita; Denise 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 747 KB

Safety, tolerability and immunogenicity

Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC-001]) and the QS-21 adjuvant in Japanese individuals with mild-to-moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial

✍ Arai, Heii; Suzuki, Hideo; Yoshiyama, Tamotsu; Lobello, Kasia; Peng, Yahong; Liu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB